U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch) · United States

FDA Rx DTC Broadcast - Major Statement in Clear, Conspicuous and Neutral Manner

Consumer-directed TV, radio and streaming ads for prescription drugs must include a major statement of the major risks presented in a clear, conspicuous and neutral manner (consumer-friendly language, audio as clear as the rest of the ad, concurrent text on TV, no distractions), plus adequate provision for full labeling.

21 CFR 202.1(e)(1); 21 U.S.C. 352(n)

What is FDA Rx DTC Broadcast - Major Statement in Clear, Conspicuous and Neutral Manner?

Consumer-directed TV, radio and streaming ads for prescription drugs must include a major statement of the major risks presented in a clear, conspicuous and neutral manner (consumer-friendly language, audio as clear as the rest of the ad, concurrent text on TV, no distractions), plus adequate provision for full labeling. Apply to TV, radio, streaming and online video or audio ads

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

broadcast_tv, broadcast_radio, ctv, ott, streaming_tv, video, audio, broadcast_tv_radio, tv_radio

When does this rule take effect?

2026-10-07

What does this rule require?

Consumer-directed TV, radio and streaming ads for prescription drugs must include a major statement of the major risks presented in a clear, conspicuous and neutral manner (consumer-friendly language, audio as clear as the rest of the ad, concurrent text on TV, no distractions), plus adequate provision for full labeling.

How can marketing teams comply?

Apply to TV, radio, streaming and online video or audio ads that name a prescription drug and its use.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch)
Jurisdiction
United States
Official citation
21 CFR 202.1(e)(1); 21 U.S.C. 352(n)
Published
2026-11-16
Effective date
2026-10-07
Channel
broadcast_tv, broadcast_radio, ctv, ott, streaming_tv, video, audio, broadcast_tv_radio, tv_radio
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, patients

Frequently asked questions

What is FDA Rx DTC Broadcast - Major Statement in Clear, Conspicuous and Neutral Manner?

Consumer-directed TV, radio and streaming ads for prescription drugs must include a major statement of the major risks presented in a clear, conspicuous and neutral manner (consumer-friendly language, audio as clear as the rest of the ad, concurrent text on TV, no distractions), plus adequate provision for full labeling.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

broadcast_tv, broadcast_radio, ctv, ott, streaming_tv, video, audio, broadcast_tv_radio, tv_radio

When does this rule take effect?

2026-10-07

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan